Halodoc 獲印尼衛生部監管沙盒監督資格

公司Halodoc频道健康科技与生物技术地区Indonesia信号类型監管與政策
来源发布Feb 4, 2026
索引Mar 10, 2026
2 min read
官方来源Halodoc Newsroom查看原始来源
LinkedInX

Regulatory approval/supervision for digital health platform.

重要性分析

This regulatory milestone in Indonesia is crucial for Halodoc's operations, providing a framework for supervised digital health innovation. It enhances trust and credibility for users and healthcare providers, potentially paving the way for broader adoption and integration of digital health services within the Indonesian healthcare system. The "supervised" status indicates compliance and a commitment to safe and effective digital health practices, which is vital for scaling in the APAC region.

区域角度

This regulatory development is highly relevant to the APAC region, particularly Southeast Asia, as it addresses the growing need for clear guidelines and oversight in the rapidly expanding digital health sector. It sets a precedent for other countries in the region looking to foster innovation while ensuring patient safety and data privacy.

What to Watch
1

Aims to safeguard digital health innovation and users.

2

Enhances trust and compliance for digital health services.

市场背景

此Regulatory & Policy反映了Indonesia市场健康科技与生物技术领域的更广泛趋势。

本周 0 条新信号 → 0% 较上周

浏览此频道
关键事实
公司Halodoc
地区Indonesia
信号类型監管與政策
来源类型企业新闻室
核心要點
1Halodoc granted 'supervised' status in Indonesian Regulatory Sandbox.
2Indicates strong partnership with Ministry of Health.
3Aims to safeguard digital health innovation and users.
Source Context

Halodoc 已取得印度尼西亞共和國衛生部監管沙盒計畫的「受監督」地位。這象徵著Halodoc與衛生部之間建立了穩固的夥伴關係與參與式監督,旨在保護數位健康創新業者、消費者及醫護人員。

频道背景
查看频道

健康科技与生物技术

此信号属于健康科技与生物技术频道。浏览相关信号,了解此发展如何融入更广泛的行业格局。

115 条频道信号
公司背景
查看公司

Halodoc

Indonesia's leading telehealth and health-tech platform

Jakarta, Indonesia

Sign in to save notes on signals.

登录